Results 61 to 70 of about 825 (170)

Effects of clozapine on adipokine secretions/productions and lipid droplets in 3T3-L1 adipocytes

Journal of Pharmacological Sciences, 2017
Clozapine, a second-generation antipsychotic (SGA), is a cause of side effects related to metabolic syndrome. The participation of serotonin 5-HT2C and histamine H1 receptors in the central nervous system has been reported as a mechanism of the weight ...
Tomomi Tsubai, Akira Yoshimi, Yoji Hamada, Makoto Nakao, Hiroshi Arima, Yutaka Oiso, Yukihiro Noda   +6 more
doaj   +1 more source

Narcolepsy initially misdiagnosed as schizophrenia: A case report

Sleep Research, Volume 3, Issue 2, Page 180-184, June 2026.
Feng Daoyi, Liu Xin, Xu Rui, He Lihua
wiley   +1 more source

Recent Developments in Radical Mediated Synthesis of Organostannanes.

Advanced Synthesis &Catalysis, Volume 367, Issue 12, June 26, 2025.
Abstract The present review aims to provide an overview of the recent developments in the preparation of aryl‐ or alkenyl stannanes via carbon‐ and tin‐centered radicals enabling chemists to synthesize organostannyl derivatives with high efficiency and under mild conditions.
Qianhang Ren, Adrian Luguera Ruiz, Maurizio Fagnoni, Stefano Protti, Di Qiu   +4 more
wiley   +1 more source

Current status and features of antipsychotic prescriptions in Japanese forensic psychiatric wards based on a forensic inpatient database

Neuropsychopharmacology Reports, Volume 45, Issue 1, March 2025.
We analyzed the current status of antipsychotics for Japanese forensic inpatients with schizophrenia spectrum disorders nationwide. Olanzapine was the most commonly prescribed antipsychotic, followed by clozapine. Clozapine was associated with longer hospitalization and a higher rate of seclusion experience.
Koji Takeda, Hiroko Kashiwagi, Keisuke Takanobu, Ryotaro Kubota, Ryo Naoe, Yuji Yamada, Junko Koike, Toshiaki Kono, Yuki Kako, Naotsugu Hirabayasi   +9 more
wiley   +1 more source

Forest plot: blonanserin (blood glucose and hemoglobin A_1c levels and QTc prolongation).

, 2014
3-a. Blood glucose. 3-b. Hemoglobin A1c. 3-c. QTc prolongation. BLO: blonanserin, HAL: haloperidol, RIS: risperidone.
Nakao Iwata (139930), Taro Kishi (519702), Yuki Matsuda (519703)   +2 more
core   +1 more source

Successful Clozapine Treatment for Treatment‐Resistant Schizophrenia With Zinc Deficiency Severe Anemia: A Case Report

Neuropsychopharmacology Reports, Volume 45, Issue 1, March 2025.
A case of severe zinc deficiency anemia after initiation of clozapine. Successful continuation of clozapine treatment with zinc supplementation. ABSTRACT Introduction Clozapine is an atypical antipsychotic drug approved for treatment‐resistant schizophrenia (TRS).
Kaoru Matsuo‐Yamamoto, Shinya Uenishi, Yuta Ishiyama, Shinichi Yamada, Yuji Kitabata, Kazuya Okamura, Sohei Kimoto   +6 more
wiley   +1 more source

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders

Neuropsychiatric Disease and Treatment, 2016
Taro Kishi,1 Yuki Matsuda,1 Shinji Matsunaga,1 Tomohiko Mukai,1,2 Masatsugu Moriwaki,1,2 Hideaki Tabuse,3 Kiyoshi Fujita,2 Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, 2Department of Psychiatry ...
Kishi T, Matsuda Y, Matsunaga S, Mukai T, Moriwaki M, Tabuse H, Fujita K, Iwata N   +7 more
doaj  

Forest plot: blonanserin (weight gain and total cholesterol and triglyceride levels).

, 2014
2-a. Weight gain. 2-b. Total cholesterol. 2-c. Triglyceride. BLO: blonanserin, HAL: haloperidol, RIS: risperidone.
Nakao Iwata (139930), Taro Kishi (519702), Yuki Matsuda (519703)   +2 more
core   +1 more source

Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials

, 2018
Introduction We conducted an updated systematic review and meta-analysis of randomized controlled trials (RCTs) comparing blonanserin with other antipsychotics (amisulpride, aripiprazole, haloperidol, paliperidone, and risperidone).
Kenji Sanada, Kiichiro Morita, Hikaru Hori, Hiroko Yanagimoto, Reiji Yoshimura, Asuka Katsuki, Yuki Matsuda, Yoshihisa Shoji, Katsuhiko Hagi, Taro Kishi, Yuki Matsui, Nakao Iwata   +11 more
core   +1 more source

Second‐generation antipsychotic‐induced dystonia: Analysis using the Japanese Adverse Drug Event Report (JADER) database

Psychiatry and Clinical Neurosciences, Volume 79, Issue 3, Page 117-124, March 2025.
Aim This study aimed to explore the comparative risks for dystonia among different second‐generation antipsychotics (SGAs), the influence of sex, and the relationship between the time‐to‐onset of dystonia and its outcomes. Methods We analyzed data from the Japanese Adverse Drug Event Report database from April 2004 to November 2023.
Takumi Ebina, Kunihiro Iwamoto, Masahiko Ando, Masashi Ikeda   +3 more
wiley   +1 more source